Cancer research focus Audubon Bioscience specializes in providing high-quality, ethically consented biospecimens with associated clinical data to scientists and pharmaceutical companies working in cancer research and precision medicine, signaling strong opportunities with oncology labs, diagnostic developers, and translational research groups.

Global collaboration With a client base of scientists worldwide and strategic partnerships, there is potential to expand business development through international research institutions, contract research organizations, and universities pursuing multicenter cancer and biomarker studies.

Strategic partnerships Recent and ongoing collaborations with Peace and Development Foundation, University of Guelph, and MicroVentures indicate openings for joint programs in ethical biospecimen procurement, environmental sustainability initiatives, and funded expansion campaigns that can be leveraged to attract similar partners.

Growth and funding readiness Revenue in the tens of millions and a track record of funding-driven expansion suggest readiness to engage investors and CROs for scaled supply agreements, larger biospecimen catalogs, and data-rich clinical annotations to support late-stage diagnostics and therapeutic development.

Operations and tech enablement Utilizing tools like QuickBooks Online, HubSpot Analytics, Google Tag Manager, and other workflow technologies, Audubon is positioned to adopt enhanced sales enablement, customer relationship management, and data-driven outreach to target oncology researchers and biotech firms seeking streamlined procurement of biospecimens.